0
Signin
countryflagUS

18889881171

AAPL 250.9362 1.1636% MSFT 439.85 0.5624% NVDA 132.26 2.5987% GOOGL 190.36 1.0403% GOOG 191.585 0.7547% AMZN 224.7026 1.8967% META 605.1 1.3245% AVGO 221.57 -0.9167% TSLA 434.8 -1.211% TSM 195.3 -0.133% LLY 758.87 -0.7637% V 315.9 1.9756% JPM 234.325 1.7168% UNH 493.79 -1.1867% NVO 103.7 -2.1329% WMT 93.89 0.3634% LVMUY 130.52 0.7721% XOM 105.67 -0.7048% LVMHF 649.5 0.6649% MA 526.755 1.3068%

Essilor International SA

Healthcare US ESLOY

119.68USD
-0.64(0.53%)

Last update at 2024-12-19T15:08:00Z

Day Range

119.68120.15
LowHigh

52 Week Range

80.77101.87
LowHigh

Fundamentals

  • Previous Close 120.32
  • Market Cap92025.53M
  • Volume452
  • P/E Ratio35.39
  • Dividend Yield1.73%
  • EBITDA5380.00M
  • Revenue TTM25351.00M
  • Revenue Per Share TTM28.51
  • Gross Profit TTM 15374.00M
  • Diluted EPS TTM2.84

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 3032.00M 2200.00M 313.00M 1534.00M 1295.00M
Minority interest -128.00000M -150.00000M 530.00M 536.00M 504.00M
Net income 2152.00M 1463.00M 85.00M 1077.00M 1087.00M
Selling general administrative 2116.00M 1982.00M 1867.00M 2000.00M 989.00M
Selling and marketing expenses 9552.00M 7234.00M 5469.00M 6249.00M 4137.00M
Gross profit 15584.00M 12231.00M 8476.00M 10818.00M 6837.00M
Reconciled depreciation 2921.00M 2461.00M 2136.00M 2121.00M 759.00M
Ebit 3187.00M 2343.00M 460.00M 1680.00M 1369.00M
Ebitda 6108.00M 4804.00M 2596.00M 3801.00M 2128.00M
Depreciation and amortization 2921.00M 2461.00M 2136.00M 2121.00M 759.00M
Non operating income net other - - - 0.00000M 0.00000M
Operating income 3157.00M 2326.00M 452.00M 1678.00M 1358.00M
Other operating expenses 21397.00M 17558.00M 13967.00M 15538.00M 9436.00M
Interest expense 156.00M 141.00M 141.00M 171.00M 72.00M
Tax provision 751.00M 587.00M 164.00M 350.00M 139.00M
Interest income 26.00M 30.00M 22.00M 53.00M 18.00M
Net interest income -148.00000M -130.00000M -141.00000M -123.00000M -55.00000M
Extraordinary items - - - 0.00000M 0.00000M
Non recurring - - - 0.00000M 0.00000M
Other items - - - 0.00000M 0.00000M
Income tax expense 751.00M 587.00M 164.00M 350.00M 139.00M
Total revenue 24494.00M 19820.00M 14429.00M 17391.00M 10800.00M
Total operating expenses 12487.00M 9969.00M 8014.00M 8965.00M 5473.00M
Cost of revenue 8910.00M 7589.00M 5953.00M 6573.00M 3963.00M
Total other income expense net -125.00000M -126.00000M -139.00000M -144.00000M -63.00000M
Discontinued operations - - - 0.00000M 0.00000M
Net income from continuing ops 2281.00M 1613.00M 149.00M 1184.00M 1156.00M
Net income applicable to common shares 2152.00M 1463.00M 85.00M 1077.00M 1083.00M
Preferred stock and other adjustments - - - 0.00000M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 60561.00M 59428.00M 52318.00M 52583.00M 46269.00M
Intangible assets 12122.00M 12290.00M 10030.00M 11300.00M 11872.00M
Earning assets - - - - -
Other current assets 258.00M 192.00M 163.00M 211.00M 219.00M
Total liab 22414.00M 23431.00M 19520.00M 17251.00M 13008.00M
Total stockholder equity 37455.00M 35186.00M 32268.00M 34796.00M 32823.00M
Deferred long term liab - - - 0.00000M 0.00000M
Other current liab 4581.00M 4841.00M 3146.00M 2915.00M 4085.00M
Common stock 81.00M 80.00M 79.00M 79.00M 77.00M
Capital stock 81.00M 80.00M 79.00M 79.00M 77.00M
Retained earnings 2152.00M 1463.00M 85.00M 1077.00M 1087.00M
Other liab 3332.00M 3356.00M 2614.00M 3151.00M 3476.00M
Good will 30734.00M 29412.00M 22658.00M 24074.00M 23241.00M
Other assets 1.00M -1.00000M 678.00M 678.00M -2.00000M
Cash 1960.00M 3293.00M 8683.00M 4836.00M 1829.00M
Cash and equivalents - - - - -
Total current liabilities 7888.00M 8667.00M 6170.00M 5617.00M 7015.00M
Current deferred revenue 3173.00M 3680.00M 2210.00M 1921.00M 3138.00M
Net debt 10244.00M 9724.00M 3212.00M 4579.00M 1938.00M
Short term debt 1010.00M 1608.00M 1160.00M 932.00M 1184.00M
Short long term debt 164.00M 1036.00M 633.00M 403.00M 1175.00M
Short long term debt total 12204.00M 13017.00M 11895.00M 9415.00M 3767.00M
Other stockholder equity 35222.00M 33643.00M 32104.00M 33640.00M 31659.00M
Property plant equipment 7757.00M 7141.00M 5101.00M 5634.00M 5167.00M
Total current assets 8640.00M 9280.00M 13720.00M 10750.00M 7041.00M
Long term investments - - - 50.40M 625.63M
Net tangible assets -5401.00000M -6514.00000M -421.00000M -578.00000M -2562.00000M
Short term investments - - 200.00M 511.00M 11.00M
Net receivables 3633.00M 3350.00M 2744.00M 3026.00M 2937.00M
Long term debt 8858.00M 8913.00M 9324.00M 6864.00M 2564.00M
Inventory 2789.00M 2445.00M 1930.00M 2166.00M 2045.00M
Accounts payable 2297.00M 2218.00M 1864.00M 1770.00M 1746.00M
Total permanent equity - - - 0.00000M 0.00000M
Noncontrolling interest in consolidated entity - - - 0.00000M 0.00000M
Temporary equity redeemable noncontrolling interests - - - 0.00000M 0.00000M
Accumulated other comprehensive income - - - 0.00000M 0.00000M
Additional paid in capital - - - 0.00000M 0.00000M
Common stock total equity - - - 0.00000M 0.00000M
Preferred stock total equity - - - 0.00000M 0.00000M
Retained earnings total equity - - - 0.00000M 0.00000M
Treasury stock - - - 0.00000M 0.00000M
Accumulated amortization - - - 0.00000M 0.00000M
Non currrent assets other 900.00M 807.00M 464.00M 760.00M 243.00M
Deferred long term asset charges - - - 0.00000M 0.00000M
Non current assets total 51920.00M 50149.00M 38598.00M 41833.00M 39230.00M
Capital lease obligations 3182.00M 3067.00M 1938.00M 2148.00M 28.00M
Long term debt total - - - 0.00000M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -2619.00000M 97.00M 287.00M -437.00000M -437.00000M
Change to liabilities 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total cashflows from investing activities -2619.00000M -8060.00000M -480.00000M -1692.00000M 38.00M
Net borrowings -1917.00000M -1447.00000M 2276.00M 2934.00M -1252.00000M
Total cash from financing activities -3580.00000M -2040.00000M 1498.00M 1379.00M -1255.00000M
Change to operating activities -356.00000M 329.00M 610.00M -7.00000M 284.00M
Net income 2281.00M 1613.00M 149.00M 1185.00M 1156.00M
Change in cash -1333.00000M -5390.00000M 3847.00M 3007.00M 670.00M
Begin period cash flow 3293.00M 8683.00M 4836.00M 1829.00M 1159.00M
End period cash flow 1960.00M 3293.00M 8683.00M 4836.00M 1829.00M
Total cash from operating activities 4783.00M 4545.00M 2953.00M 3299.00M 1881.00M
Issuance of capital stock 37.00M 34.00M 36.00M 32.00M 46.00M
Depreciation 2921.00M 2461.00M 2136.00M 2121.00M 759.00M
Other cashflows from investing activities 85.00M -65.00000M 8.00M -12.00000M -5.00000M
Dividends paid -454.00000M -138.00000M -503.00000M -887.00000M 484.00M
Change to inventory - - - 0.00000M 0.00000M
Change to account receivables - - - 0.00000M 0.00000M
Sale purchase of stock -431.00000M -317.00000M -159.00000M 4186.00M -511.00000M
Other cashflows from financing activities -2277.00000M -819.00000M 2124.00M 3558.00M -524.00000M
Change to netincome 17.00M 334.00M 103.00M 108.00M -227.00000M
Capital expenditures 1572.00M 1030.00M 650.00M 903.00M 710.00M
Change receivables - - - 0.00000M 0.00000M
Cash flows other operating - - - 0.00000M 0.00000M
Exchange rate changes - - - 0.00000M 0.00000M
Cash and cash equivalents changes - - - 0.00000M 0.00000M
Change in working capital -407.00000M 367.00M 673.00M -52.00000M 259.00M
Stock based compensation 191.00M 160.00M 156.00M 154.00M 76.00M
Other non cash items -203.00000M -56.00000M -161.00000M -109.00000M -369.00000M
Free cash flow 3211.00M 3515.00M 2303.00M 2396.00M 1171.00M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ESLOY
Essilor International SA		 -0.64 0.53% 119.68 35.39 24.81 3.63 2.20 4.00 16.25
ISRG
Intuitive Surgical Inc		 3.11 0.59% 529.58 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 -3.5 1.44% 240.00 35.71 25.13 3.62 2.23 4.00 16.25
BDX
Becton Dickinson and Company		 1.06 0.47% 225.15 37.72 15.92 3.25 2.49 4.08 17.10
ALC
Alcon AG		 0.01 0.01% 84.75 36.95 25.13 4.40 2.32 4.80 36.97

Reports Covered

Stock Research & News

View All

Profile

EssilorLuxottica Société anonyme engages in design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses in Europe, Middle East, Africa, Latin America, Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Crizal, Essilor, Eyezen, Stellest, Xperio, Optifog, Satisloh, Barberini, Shamir, Nikon, KODAK Lens, Oakley, OPTIFOG, Ray-Ban, Transitions, Vailux, and Xperio brands. It also provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Alain Mikli, Costa del Mar, Native Eyewear, Luxottica, Sferoflex, Heritage, Sensaya, Miki Ninn, DbyD, Unofficial and Seen, Arnette, Vogue Eyewear, Bolon, Molsion, and Ossé, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of physical stores or its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

Essilor International SA

1-5 rue Paul CEzanne, Paris, France, 75008

Key Executives

Name Title Year Born
Mr. Francesco Milleri Chairman & CEO 1959
Mr. Paul du Saillant Deputy CEO & Director 1959
Mr. Stefano Grassi Chief Financial Officer 1973
Marco Catalani Head of Corp. Communications NA
Ariel Bauer Co-Head of Investor Relations NA
Giorgio Iannella Co-Head of Investor Relations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.